Key Trends Influencing the Growth of the Chronic Cough Market in 2025: Innovative Product Developments Transforming The Landscape Of The Chronic Cough Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Chronic Cough Market Through 2025?
The market size for chronic cough has demonstrated significant expansion in the past few years. The projections indicate an increase from $8.22 billion in 2024 to $8.9 billion in 2025, marking a compound annual growth rate (CAGR) of 8.3%. This growth during the historic period can be connected to the frequency of respiratory disorders, impact of environmental factors and air pollution, usage of tobacco and smoking products, respiratory infections, as well as allergies and sensitivity to the environment.

What's the Projected Size of the Global Chronic Cough Market by 2029?
The market for chronic cough is predicted to experience substantial expansion in the forthcoming years. The projected growth will lead to a market value of $12.89 billion in 2029, at a compound annual growth rate (CAGR) of 9.7%. The surge in growth during the forecast period can be credited to the development of new therapies targeting specific pathways, enhanced comprehension of reflux-associated cough, worldwide campaigns for smoking cessation, and policies related to environmental and occupational health. The fundamental trends for the forecast period encompass improvements in diagnostic technologies, patient-oriented strategies, innovative therapies in neurogenic cough, telehealth solutions for managing chronic cough, and research on central sensitization.

View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

Top Growth Drivers in the Chronic Cough Industry: What's Accelerating the Market?
The chronic cough market is projected to grow due to an increase in the incidences of cough. The reflex action that forcefully ejects air from the lungs in response to irritation, mucus, or foreign substances, is identified as a cough. A cough is labeled as chronic if it persists for a minimum of eight weeks. Thus, an upsurge in cough cases escalates the occurrences of chronic cough as well. For instance, the Florida Health, a healthcare department based in the US, reported a total of 80 patients with cough in 2021, indicating incidences of 41.0 and 1.4 per 100,000 years, respectively, in March 2022. Additionally, in 2023, there were 28 instances of pertussis across 13 countries. Similarly, the Statens Serum Institut, a Denmark-based disease surveillance department, noted a 41% jump in pertussis cases from November 2022 to April 2023, compared to the same period the previous year, as reported in March 2022. Consequently, the increasing prevalence of cough is stimulating the expansion of the chronic cough market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp

What Trends Will Shape the Chronic Cough Market Through 2029 and Beyond?
Large corporations active in the chronic cough market are focusing their efforts on designing inventive products like biosimilars to bolster their market standing. These biosimilars are utilised in the treatment of various conditions including cancer, autoimmune diseases and diabetes, thereby offering a more cost-efficient substitute to existing biologics. In July 2024, a pharmaceutical firm based in Switzerland known as Sandoz launched its biosimilar product Pyzchiva (ustekinumab) throughout Europe. The product targets medical conditions that involve chronic inflammation such as plaque psoriasis, psoriatic arthritis, and Crohn's disease. Notably, this biosimilar is remarkable for being the first of its kind available in Europe covering all reference medication strengths, inclusive of the starting dosage for Crohn's disease. Sandoz collaborated with Samsung Bioepis to develop this, with the intention of widening the access to efficient treatments for the many affected by these medical conditions. The launch of this product signifies Sandoz's commitment to facilitate affordable healthcare solutions and enhance patients' quality of life across Europe.

What Are the Main Segments in the Chronic Cough Market?
The chronic cough market covered in this report is segmented -

1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes
2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route Of Administrations
3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:
1) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines
2) By Corticosteroids: Inhaled Corticosteroids, Systemic Corticosteroids
3) By Decongestants: Oral Decongestants, Nasal Decongestants
4) By Combination Drug: Antihistamine And Decongestant Combinations, Cough Suppressant And Expectorant Combinations
5) By Antibiotics: Macrolides, Penicillins, Cephalosporins
6) By Acid Blockers: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists
7) By Other Drug Classes: Mucolytics, Cough Suppressants, Herbal Remedies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12109&type=smp

Which Top Companies are Driving Growth in the Chronic Cough Market?
Major companies operating in the chronic cough market include Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Glaxo SmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.

Which Regions Will Dominate the Chronic Cough Market Through 2029?
North America was the largest region in the chronic cough market in 2024. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12109

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.